ITMI20051572A1 - Composizione farmaceutica contenente come sostanza attiva una frazione proteica estratta da embrioni di ovipari nel periodo del differenziamento cellulare e relativo processo di preparazione - Google Patents

Composizione farmaceutica contenente come sostanza attiva una frazione proteica estratta da embrioni di ovipari nel periodo del differenziamento cellulare e relativo processo di preparazione

Info

Publication number
ITMI20051572A1
ITMI20051572A1 IT001572A ITMI20051572A ITMI20051572A1 IT MI20051572 A1 ITMI20051572 A1 IT MI20051572A1 IT 001572 A IT001572 A IT 001572A IT MI20051572 A ITMI20051572 A IT MI20051572A IT MI20051572 A1 ITMI20051572 A1 IT MI20051572A1
Authority
IT
Italy
Prior art keywords
oviparians
embryos
period
pharmaceutical composition
composition containing
Prior art date
Application number
IT001572A
Other languages
English (en)
Inventor
Alberto Astaldi
Pier Mario Biava
Mariano Bizzarri
Original Assignee
Alberto Astaldi
Pier Mario Biava
Mariano Bizzarri
Monteres S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alberto Astaldi, Pier Mario Biava, Mariano Bizzarri, Monteres S R L filed Critical Alberto Astaldi
Priority to IT001572A priority Critical patent/ITMI20051572A1/it
Priority to PCT/EP2006/065199 priority patent/WO2007020222A2/en
Publication of ITMI20051572A1 publication Critical patent/ITMI20051572A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/65—Amphibians, e.g. toads, frogs, salamanders or newts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IT001572A 2005-08-12 2005-08-12 Composizione farmaceutica contenente come sostanza attiva una frazione proteica estratta da embrioni di ovipari nel periodo del differenziamento cellulare e relativo processo di preparazione ITMI20051572A1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT001572A ITMI20051572A1 (it) 2005-08-12 2005-08-12 Composizione farmaceutica contenente come sostanza attiva una frazione proteica estratta da embrioni di ovipari nel periodo del differenziamento cellulare e relativo processo di preparazione
PCT/EP2006/065199 WO2007020222A2 (en) 2005-08-12 2006-08-10 Pharmaceutical composition containing as active substance a protein fraction extracted from oviparous embryos at the cell differentiation stage and preparation process thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001572A ITMI20051572A1 (it) 2005-08-12 2005-08-12 Composizione farmaceutica contenente come sostanza attiva una frazione proteica estratta da embrioni di ovipari nel periodo del differenziamento cellulare e relativo processo di preparazione

Publications (1)

Publication Number Publication Date
ITMI20051572A1 true ITMI20051572A1 (it) 2007-02-13

Family

ID=37492494

Family Applications (1)

Application Number Title Priority Date Filing Date
IT001572A ITMI20051572A1 (it) 2005-08-12 2005-08-12 Composizione farmaceutica contenente come sostanza attiva una frazione proteica estratta da embrioni di ovipari nel periodo del differenziamento cellulare e relativo processo di preparazione

Country Status (2)

Country Link
IT (1) ITMI20051572A1 (it)
WO (1) WO2007020222A2 (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2337537B8 (es) * 2008-03-19 2011-08-01 Joan Cunill Aixela Preparado alimenticio y composicion farmaceutica que contiene un extracto embrionario y sus respectivos usos.
IT1400147B1 (it) * 2010-03-16 2013-05-17 Univ Roma Uso di un campo morfogenetico per la reversione del fenotipo di cellule tumorali
US9750773B2 (en) * 2014-08-07 2017-09-05 Michele BIAVA Factors extracted from fish embryos and use of mixtures thereof in the control of stem cell multiplication and differentiation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888172A (en) * 1982-09-23 1989-12-19 Alfaceu Corporation Pharmaceutical for treating tumors and methods for making it
US5648340A (en) * 1991-10-31 1997-07-15 Barnea; Eytan R. Gestational agents for controlling cell proliferation
IT1284571B1 (it) * 1996-09-20 1998-05-21 Adriana Carluccio Composizione antitumorale contenente come sostanza attiva un estratto embrionale o di utero gravido e relativo procedimento di preparazione
ITMI20021362A1 (it) * 2002-06-20 2003-12-22 Biava Pier Mario Impiego di un estratto embrionale animale come sostanza nutriente e integratore dietetico-nutraceutico
TW200423951A (en) * 2002-11-13 2004-11-16 Ming-Chung Wong Method of preparing anti-angiogenic drug from cartilage and chondrocytes and methods of use

Also Published As

Publication number Publication date
WO2007020222A2 (en) 2007-02-22
WO2007020222A3 (en) 2007-04-12

Similar Documents

Publication Publication Date Title
IL190951A0 (en) Method of acting upon organism by targeted delivery of biologicaly active substances into mitochondria, pharmaceutical composition for carrying out said method, and compound used for the purpose
SMT201600398B (it) Inibitori di proteina chinasi (varianti), uso di questi nel trattamento di malattie oncologiche e composizione farmaceutica basata su questi
BRPI1008971A2 (pt) métodos para preparar uma proteína biológica condicionalmente ativa, e um modificador de resposta biológica condicionalmente ativo, proteína biológica condicionalmente ativa, e, composição farmacêutica
RU2398586C3 (ru) Фармацевтическая композиция
BRPI0821115A2 (pt) Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto
BRPI0910461A8 (pt) hormônio de estimulação do folículo recombinante, sua composição farmacêutica, seu método de produção e seu uso.
UY31673A1 (es) "derivados heterocíclicos de urea y métodos de uso de los mismos-211"
BRPI0812851A2 (pt) Composto, composição farmacêutica, métodos para o tratamento de uma doença e de uma condição em um indivíduo, processo para preparar um composto, e, uso de um composto
NO20075628L (no) Farmasøytiske formuleringer
ITBO20050123A1 (it) Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
DE102005001078A8 (de) Glaspulver, insbesondere biologisch aktives Glaspulver und Verfahren zur Herstellung von Glaspulver, insbesondere biologisch aktivem Glaspulver
BRPI1010621A2 (pt) derivado de imidazoquinolinonas, sua composição farmacêutica e seu uso
CL2008000403A1 (es) Compuestos derivados de pentafluorotiobenzamido-acetonitrilo; composicion farmaceutica; y uso para tratar una infestacion por parasitos.
CL2005003456A1 (es) Proceso de preparacion del beta-anomero enriquecido de clorhidrato de gemcitabina; compuesto intermediario involucrado en dicho proceso; y su proceso de preparacion.
BRPI0915552A2 (pt) derivados de ciclosporina, seu uso e sua composição farmacêutica
DK2029134T3 (da) Stabiliserede farmaceutiske præparater omfattende fesoterodin
CL2013000201A1 (es) Composiciones farmaceuticas combinadas que comprenden una forma activada potenciada de anticuerpos contra la proteina s-100 de cerebro y una forma activada potenciada de anticuerpos contra nos endotelial; metodo de tratamiento del vertigo la cinetosis y la distonia vegetativa-vascular.
ITRM20050393A1 (it) Sistema di rilascio controllato di sostanze farmacologicamente attive, processo di preparazione e impieghi in campo medico.
ATE397937T1 (de) Medikament zur behandlung von pilzinfektionen; insbesondere aspergillose
BRPI0913401A2 (pt) pregn-4 eno-21, 17-carbolactonas substituídas no anel c e preparados farmacêuticos contendo as mesmas
ITMI20051572A1 (it) Composizione farmaceutica contenente come sostanza attiva una frazione proteica estratta da embrioni di ovipari nel periodo del differenziamento cellulare e relativo processo di preparazione
BRPI0614413A2 (pt) composto, e, composição farmacêutica
FR2920774B1 (fr) Nouveaux derives de n-phenul acatamide, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contentant
BRPI0614481A2 (pt) composto, composição farmecêutica, uso do composto, e, método de tratamento de distúrbios mediados por mglur5
SM200500011B (it) Una composizione farmaceutica antimicobatterica